JPMorgan Chase & Co’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,532
| Closed | -$285K | – | 6387 |
|
|
2022
Q4 | $285K | Buy |
25,532
+23,817
| +1,389% | +$266K | ﹤0.01% | 4046 |
|
|
2022
Q3 | $10K | Buy |
1,715
+719
| +72% | +$4.19K | ﹤0.01% | 5078 |
|
|
2022
Q2 | $4K | Sell |
996
-7,288
| -88% | -$29.3K | ﹤0.01% | 5364 |
|
|
2022
Q1 | $97K | Buy |
8,284
+1,720
| +26% | +$20.1K | ﹤0.01% | 4763 |
|
|
2021
Q4 | $120K | Buy |
6,564
+2,298
| +54% | +$42K | ﹤0.01% | 4753 |
|
|
2021
Q3 | $51K | Hold |
4,266
| – | – | ﹤0.01% | 4957 |
|
|
2021
Q2 | $73K | Sell |
4,266
-71,863
| -94% | -$1.23M | ﹤0.01% | 4857 |
|
|
2021
Q1 | $1.39M | Buy |
76,129
+48,041
| +171% | +$879K | ﹤0.01% | 3447 |
|
|
2020
Q4 | $528K | Buy |
28,088
+18,303
| +187% | +$344K | ﹤0.01% | 3715 |
|
|
2020
Q3 | $199K | Sell |
9,785
-5,583
| -36% | -$114K | ﹤0.01% | 3736 |
|
|
2020
Q2 | $444K | Buy |
15,368
+6,805
| +79% | +$197K | ﹤0.01% | 3344 |
|
|
2020
Q1 | $300K | Buy |
8,563
+1,133
| +15% | +$39.7K | ﹤0.01% | 3543 |
|
|
2019
Q4 | $182K | Buy |
+7,430
| New | +$182K | ﹤0.01% | 3846 |
|